Mostrar el registro sencillo del ítem

dc.contributor.authorVerjan García, Noelspa
dc.date.accessioned2009-01-01 00:00:00
dc.date.accessioned2022-06-13T17:41:17Z
dc.date.available2009-01-01 00:00:00
dc.date.available2022-06-13T17:41:17Z
dc.date.issued2009-01-01
dc.identifier.issn0121-3709
dc.identifier.urihttps://repositorio.unillanos.edu.co/handle/001/2471
dc.description.abstractI would like to initiate this document by making a brief description of the term Biotechnology, hoping to not hurt the feelings of many other professionals better versed than I, on the details of this science, as the application of traditional and/or scientific knowledge to manipulate microorganisms, cells or even higher organisms, directed to supply goods and services to the daily growing human population. With almost 30-year-old, biotechnology, driven by the ability to transplant a gene from one organism into another to introduce novel functionality in the receiving organism, has evolved to repro- gram cellular behavior or incorporate increasingly com- plex biosynthetic pathways (to produce novel metabolic products or to achieve greater system integration) or genetic regulatory constructs (to modulate the activity of recombinant genes in space and time) (Bhalerao, 2009). Biotechnology one of the riskiest industries has achieved a dynamic growth and unparalleled discovery, outstanding advances and contributions to human and animal medicine. This has mainly been possible throughout the exploration of diverse unicellular and multicellular genomes, the genes and the proteins they encode, and together with the development of dozens of technologies, reach every day a better understand- ing of cell biology, homeostasis and disease. Thus, biotechnology has established as an industry, where any bio-product can be patentable.spa
dc.description.abstractI would like to initiate this document by making a brief description of the term Biotechnology, hoping to not hurt the feelings of many other professionals better versed than I, on the details of this science, as the application of traditional and/or scientific knowledge to manipulate microorganisms, cells or even higher organisms, directed to supply goods and services to the daily growing human population. With almost 30-year-old, biotechnology, driven by the ability to transplant a gene from one organism into another to introduce novel functionality in the receiving organism, has evolved to repro- gram cellular behavior or incorporate increasingly com- plex biosynthetic pathways (to produce novel metabolic products or to achieve greater system integration) or genetic regulatory constructs (to modulate the activity of recombinant genes in space and time) (Bhalerao, 2009). Biotechnology one of the riskiest industries has achieved a dynamic growth and unparalleled discovery, outstanding advances and contributions to human and animal medicine. This has mainly been possible throughout the exploration of diverse unicellular and multicellular genomes, the genes and the proteins they encode, and together with the development of dozens of technologies, reach every day a better understand- ing of cell biology, homeostasis and disease. Thus, biotechnology has established as an industry, where any bio-product can be patentable.eng
dc.format.mimetypeapplication/mswordspa
dc.format.mimetypeapplication/pdfspa
dc.format.mimetypetext/htmlspa
dc.language.isospaspa
dc.publisherUniversidad de los Llanosspa
dc.rightsOrinoquia - 2014spa
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/spa
dc.sourcehttps://orinoquia.unillanos.edu.co/index.php/orinoquia/article/view/237spa
dc.subjectcaninospa
dc.subjecthistiocitosis malignaspa
dc.subjectneoplasia mesenquimalspa
dc.subjecttumor células redondasspa
dc.subjectcaninespa
dc.subjectmalignant histiocytocisspa
dc.subjectmesenchimal neoplasmspa
dc.subjectround cell tumorspa
dc.subjecthistiocitoses malignaspa
dc.subjecttumor de células redondasspa
dc.titleBiotechnology, beginning with recombinant DNA toward a personalized medicinespa
dc.typeArtículo de revistaspa
dc.typeJournal Articleeng
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localSección Artículosspa
dc.type.localSección Articleseng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.identifier.doi10.22579/20112629.237
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.identifier.eissn2011-2629
dc.identifier.urlhttps://doi.org/10.22579/20112629.237
dc.relation.bitstreamhttps://orinoquia.unillanos.edu.co/index.php/orinoquia/article/download/237/442
dc.relation.bitstreamhttps://orinoquia.unillanos.edu.co/index.php/orinoquia/article/download/237/673
dc.relation.bitstreamhttps://orinoquia.unillanos.edu.co/index.php/orinoquia/article/download/237/672
dc.relation.citationeditionNúm. 1 , Año 2009spa
dc.relation.citationendpage74
dc.relation.citationissue1spa
dc.relation.citationstartpage69
dc.relation.citationvolume13spa
dc.relation.ispartofjournalOrinoquiaspa
dc.title.translatedBiotechnology, beginning with recombinant DNA toward a personalized medicineeng
dc.type.contentTextspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Ficheros en el ítem

FicherosTamañoFormatoVer
Orinoquia-237.pdf535.4Kbapplication/pdfVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Orinoquia - 2014
Excepto si se señala otra cosa, la licencia del ítem se describe como Orinoquia - 2014